Niya Biotech
Generated 5/25/2026
Executive Summary
Niya Biotech, a division of Albia Biocare, is a PCD pharma franchise company headquartered in Jalandhar, Punjab, India, established in 2019. It offers a comprehensive portfolio of herbal and allopathic pharmaceutical products across more than 12 therapeutic categories, including analgesics, gastroenterology, antibiotics, and dermatology. The company manufactures in GMP/WHO-certified facilities and provides franchise partners with monopoly rights, technical support, and promotional assistance. With a focus on affordable, high-quality dosage forms such as tablets, capsules, and injectables, Niya Biotech has positioned itself as a reliable partner in the Indian pharmaceutical franchise market. The company operates at a commercial stage with an employee base of 50–200 and aims to expand its reach through its franchise model.
Upcoming Catalysts (preview)
- Q3 2026Expansion of product portfolio into new therapeutic categories60% success
- Q4 2026Onboarding of new franchise partners in underpenetrated regions70% success
- TBDObtaining additional regulatory certifications (e.g., ISO or WHO-GMP) for manufacturing facilities80% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)